Reported Reactions

Devices › Tissue adhesive for the topical approximation of skin

Device brand name · Topical skin adhesive

Liquiband Exceed: medical device reports filed with FDA

158 reports name it, 2017–2026. Manufacturer given most often on reports: Advanced Medical Solutions. Product code MPN.

158
device reports naming the brand
0% of all MAUDE reports · about 17 a year
8
reports, 12 months to August 2026
2 in the 12 months before
1.3%
classified as malfunction
34.1% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 158 reports that name the brand "Liquiband Exceed" (topical skin adhesive), received between April 2017 and June 2026; the manufacturer given most often on reports is Advanced Medical Solutions. Spellings of one product vary from report to report.

8 reports arrived in the 12 months to August 2026, up 300% from 2 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.7%) and malfunction (1.3%); across all tissue adhesive for the topical approximation of skin reports (product code MPN) death is recorded in 0.2% and malfunction in 34.1%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are patient-device incompatibility (19.6%), insufficient device problem information (10.8%) and loss of or failure to bond (1.3%). The patient problems coded most often are reaction, hypersensitivity/allergic reaction and local reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

024Sep 2021: 2Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 4May 2022: 0Jun 2022: 3Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 2Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 1Nov 2025: 1Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 2Apr 2026: 2May 2026: 1Jun 2026: 1Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

022432017: 3320172018: 1320182019: 2720192020: 4320202021: 2520212022: 720222025: 420252026: 62026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.7%156
Malfunction1.3%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.1%155
Voluntary report0%0
User facility report0%0
Distributor report1.9%3
Not given0%0

Grey bar: all 3,646 reports carrying product code MPN. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Patient-device incompatibilitythe device did not suit the patient3119.6%3.9%
Insufficient device problem information1710.8%2.5%
Loss of or failure to bond21.3%0.5%
Material erosion21.3%0.1%
Device operates differently than expectedthe device behaved unexpectedly10.6%1%
Fluid/blood leak10.6%5.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Reactiona reaction, type not specified6440.5%
Hypersensitivity/allergic reaction2113.3%
Local reaction1710.8%
Rashskin rash127.6%
Skin inflammation/ irritation127.6%
Wound dehiscencea wound reopened117%
Tissue damage106.3%
Wheal(s)95.7%
Post operative wound infection74.4%
Skin inflammation63.8%
Itching sensation53.2%
Cellulitisa skin infection31.9%
Contact dermatitis21.3%
Inflammationinflammation21.3%
Partial thickness (second degree) burn21.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureLiquiband ExceedProduct code MPNAll MAUDE reports
Reports1583,64626,136,888
Share of that pool—4.3%0%
Classified as death, per 1,000 reports029
Classified as injury98.7%54.9%36.2%
Classified as malfunction1.3%34.1%62.3%
Filed by the manufacturer98.1%94.5%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code MPN

BrandReportsLatest 12 monthsClassified as death
Dermabond Advanced 0 7ml - 12ea557590%
Dermabond Topical Skin Adhesive47600.4%
Dermabond Advanced Topical Skin Adhesive37100%
Histoacryl Blue 0 5ml28000%
Dermabond Unknown Product204150.5%
DermaBond Advanced179540%
Dermabond16810%
Prineo Skin Closure System46000%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Liquiband Exceed reports

How many FDA reports name Liquiband Exceed?

158 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 8 in the latest 12 months.

What kinds of events are reported?

injury (98.7%) and malfunction (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

patient-device incompatibility (19.6%), insufficient device problem information (10.8%), loss of or failure to bond (1.3%), material erosion (1.3%) and device operates differently than expected (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.1%) and distributor reports (1.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Liquiband Exceed was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.